BackgroundTo determine the patterns and development pathways of pulmonary abnormalities in patients with rheumatoid arthritis (RA).MethodsWe conducted a retrospective cohort study of consecutive RA patients who underwent high-resolution CT (HRCT) before and during biologic therapy. The presence of and change in 20 pulmonary lesions were recorded. Patterns of pre-existing and new lesions were examined by cluster analysis and tested for a correlation between pre-existing and new lesions.ResultsThe subjects were 208 patients (mean age, 59.2 years; mean disease duration, 7.9 years). The mean duration between HRCT examinations was 3.3 years. Pulmonary abnormalities were found in 70% of the patients: interstitial lung disease (ILD) in 39%, nodular lesions in 22%, and airway disease (AD) in 55%. There were commonly several different lesions in the same patient, and coexistence patterns were detected. In patients with abnormalities, AD was a shared abnormality. The incidence of pulmonary abnormalities was 10.5/100 person-years. Bronchiolitis was identified as the initial lesion. In patients with pre-existing abnormalities, a variety of new abnormalities developed in several patterns; e.g., ILD and progression of AD occurred in patients with AD. Strong correlation was found between new ground-glass opacity and each of pre-existing AD and honeycombing.ConclusionsPulmonary abnormalities exist and develop in patterns rather than at random. Based on the present findings, we propose the following development pathway for pulmonary abnormalities in RA: the initial lesion is bronchiolitis, which leads to the formation of complex AD, from which a variety of pulmonary lesions arise, particularly ILDs.